A study co-authored by researchers from the University of Texas has found how certain cancers resist immunotherapy by preventing the immune system from activating. The team discovered that a key element of the immune system, NKG2A, cannot engage with cancer cells without a particular trigger, and the study’s findings could help develop more effective immunotherapy drugs.
Botnets leverage decade-old D-Link vulnerabilities in new attack campaigns
A new report from FortiGuard Labs has revealed the activities of two botnets, FICORA and CAPSAICIN, exploiting vulnerabilities in legacy D-Link devices. The report stresses
